Los Angeles, CALIFORNIA4 Active Studies

Lupus Nephritis Clinical Trials in Los Angeles, CALIFORNIA

Find 4 actively recruiting lupus nephritis clinical trials in Los Angeles, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
1,094
Enrolling

Recruiting Lupus Nephritis Studies in Los Angeles

RecruitingLos Angeles, CALIFORNIANCT05126277

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

This trial will evaluate efficacy, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or every 12 weeks (q12w) compared to placebo, in combination with SoC, in adult p...

420 participants
Novartis Pharmaceuticals
View Study Details
RecruitingLos Angeles, CALIFORNIANCT05138133

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

The purpose of this study is to evaluate the efficacy and safety of IV antifrolumab in adult patients with Active Proliferative Lupus Nephritis...

360 participants
AstraZeneca
View Study Details
RecruitingLos Angeles, CALIFORNIANCT05268289

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment....

240 participants
Novartis Pharmaceuticals
View Study Details
RecruitingLos Angeles, CALIFORNIANCT05201469

VIBRANT: VIB4920 for Active Lupus Nephritis

This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in parti...

74 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details

About Lupus Nephritis Clinical Trials in Los Angeles

Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.

There are currently 4 lupus nephritis clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 1,094 participants. Research is being sponsored by Novartis Pharmaceuticals, AstraZeneca, National Institute of Allergy and Infectious Diseases (NIAID). Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Nephritis Clinical Trials in Los Angeles — FAQ

Are there lupus nephritis clinical trials in Los Angeles?

Yes, there are 4 lupus nephritis clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What lupus nephritis treatments are being tested?

The 4 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.

Data updated March 2, 2026 from ClinicalTrials.gov